Research roundup

The latest in research news, as gathered by Debbie Rigby Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis This article reviews the pharmacokinetic and pharmacodynamic properties of the sofosbuvir plus ledipasvir (SOF/LDV) fixed dose combination for the treatment of hepatitis C virus (HCV). The SOF/LDV fixed dose combination has good pharmacological

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous How agricultural antibiotic use affects resistance
Next Forum: Safety net delays By Medicare